Aprepitant Intravenous and Ustekinumab Intravenous Infusion
Determining the interaction of Aprepitant Intravenous and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Intravenous-Ustekinumab Subcutaneous
- Aprepitant Intravenous-Ustekinumab Subcutaneous Injection
- Aprepitant Intravenous-Ustell
- Aprepitant Intravenous-UTA
- Aprepitant Intravenous-UTA Capsules
- Aprepitant Intravenous-UTAC tablets
- Ustekinumab Intravenous Infusion-Aprepitant Oral Suspension
- Ustekinumab Intravenous Infusion-Aprepitant/Fosaprepitant Dimeglumine
- Ustekinumab Intravenous Infusion-Apresazide
- Ustekinumab Intravenous Infusion-Apresoline
- Ustekinumab Intravenous Infusion-Apresoline Injection
- Ustekinumab Intravenous Infusion-Apri